(NYSEMKT: CATX) Perspective Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.82%.
Perspective Therapeutics's earnings in 2026 is -$122,907,000.On average, 18 Wall Street analysts forecast CATX's earnings for 2026 to be -$122,159,617, with the lowest CATX earnings forecast at -$150,296,421, and the highest CATX earnings forecast at -$112,849,113. On average, 13 Wall Street analysts forecast CATX's earnings for 2027 to be -$137,471,835, with the lowest CATX earnings forecast at -$175,269,344, and the highest CATX earnings forecast at -$106,509,275.
In 2027, CATX is forecast to generate -$128,861,731 in earnings, with the lowest earnings forecast at -$170,414,840 and the highest earnings forecast at -$96,365,534.